© 2019 Dendrogenix

Avenue de l’Hôpital 11 -4000 Liège - Belgium

Dendrogenix is a biopharmaceutical company based in Liége (Belgium) dedicated to developing first in class molecules named “Dendrogenins” that address important medical needs in the field of neurodegeneratives diseases in particular in Hearing Loss indication, and in the field of Cancer.